Verinata Health, Inc.
Verinata Health, Inc., a pioneering company in the field of prenatal genetic testing, is headquartered in the United States. Founded in 2010, Verinata has established itself as a leader in non-invasive prenatal testing (NIPT), providing expectant parents with critical insights into fetal health. The company’s flagship product, the Verifi® test, stands out for its accuracy and reliability, utilising advanced genomic technologies to assess the risk of chromosomal conditions. With a strong presence across major operational regions in North America, Verinata Health has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. The company is recognised for its commitment to innovation and quality, making it a trusted name in the reproductive health industry. Verinata continues to shape the future of prenatal care, empowering families with essential information for informed decision-making.
DitchCarbon Score
How does Verinata Health, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Verinata Health, Inc.'s score of 86 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Verinata Health, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Illumina, Inc., and therefore, any climate commitments or emissions data would be inherited from its parent organisation. As part of its climate strategy, Verinata Health follows the initiatives set forth by Illumina, Inc. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements have not been disclosed for Verinata Health itself. The absence of direct emissions data suggests that Verinata Health is still in the process of establishing its own climate commitments or may rely on the broader corporate strategies of Illumina, Inc. to guide its environmental impact efforts. As such, the company is positioned within an industry context that increasingly prioritises sustainability and carbon footprint reduction, aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 12,489,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 21,915,000 | 00,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 238,110,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Verinata Health, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
